Skip to main content
  • Harmony TPV Safe, Effective at 1 Year in Treating Severe PR – Pooled Analysis

    The largest cohort to date of patients with congenital heart disease and severe pulmonary regurgitation (PR) who received the Harmony transcatheter pulmonary valve demonstrated favorable clinical and hemodynamic outcomes at 1 year.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details